Selected research
Market Outlook & Growth Opportunities
Global Microfluidic Chip Solution Market Outlook and Growth Opportunities 2026
Market perspective
The global Microfluidic Chip Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Microfluidic Chip Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Microfluidic Chip Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Microfluidic Chip Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Microfluidic Chip Solution market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Microfluidic Chip Solution market include Singleron, Suzhou WenHao Microfluidic Technology, Shenzhen Micropoint Biotechnologies, FluidicLab, I'M MICROSPHERE, Thermo-Fisher-Scientific, Micro Systems, LabSmith and KYODO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Microfluidic Chip Solution market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Microfluidic Chip Solution and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Microfluidic Chip Solution revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Microfluidic Chip Solution market.
Microfluidic Chip Solution Segment by Company
Singleron
Suzhou WenHao Microfluidic Technology
Shenzhen Micropoint Biotechnologies
FluidicLab
I'M MICROSPHERE
Thermo-Fisher-Scientific
Micro Systems
LabSmith
KYODO
Fivephoton Biochemicals
Enplas
Dolomite
CPS Fluidics
Bio-Rad-Laboratories
Atomica
Agilent-Technologies
AGC Inc.
Microfluidic Chip Solution Segment by Type
Pre-made Chip
Custom Chip
Microfluidic Chip Solution Segment by Application
Chemical Analysis
Environmental Monitoring
Biomedical Science
Others
Microfluidic Chip Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Microfluidic Chip Solution status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Microfluidic Chip Solution key companies, revenue, market share, and recent developments.
3. To split the Microfluidic Chip Solution breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Microfluidic Chip Solution market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Microfluidic Chip Solution significant trends, drivers, influence factors in global and regions.
6. To analyze Microfluidic Chip Solution competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microfluidic Chip Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microfluidic Chip Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microfluidic Chip Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Microfluidic Chip Solution industry.
Chapter 3: Detailed analysis of Microfluidic Chip Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Microfluidic Chip Solution in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Microfluidic Chip Solution in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Pre-made Chip
- Custom Chip
Applications
- Chemical Analysis
- Environmental Monitoring
- Biomedical Science
- Others
Companies covered
- Singleron
- Suzhou WenHao Microfluidic Technology
- Shenzhen Micropoint Biotechnologies
- FluidicLab
- I'M MICROSPHERE
- Thermo-Fisher-Scientific
- Micro Systems
- LabSmith
- KYODO
- Fivephoton Biochemicals
- Enplas
- Dolomite
- CPS Fluidics
- Bio-Rad-Laboratories
- Atomica
- Agilent-Technologies
- AGC Inc.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Microfluidic Chip Solution Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Microfluidic Chip Solution Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Microfluidic Chip Solution Market Dynamics
- 2.1 Microfluidic Chip Solution Industry Trends
- 2.2 Microfluidic Chip Solution Industry Drivers
- 2.3 Microfluidic Chip Solution Industry Opportunities and Challenges
- 2.4 Microfluidic Chip Solution Industry Restraints
3 Microfluidic Chip Solution Market by Company
- 3.1 Global Microfluidic Chip Solution Company Revenue Ranking in 2025
- 3.2 Global Microfluidic Chip Solution Revenue by Company (2021-2026)
- 3.3 Global Microfluidic Chip Solution Company Ranking (2024-2026)
- 3.4 Global Microfluidic Chip Solution Company Manufacturing Base and Headquarters
- 3.5 Global Microfluidic Chip Solution Company Product Type and Application
- 3.6 Global Microfluidic Chip Solution Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Microfluidic Chip Solution Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Microfluidic Chip Solution Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Microfluidic Chip Solution Market by Type
- 4.1 Microfluidic Chip Solution Type Introduction
- 4.1.1 Pre-made Chip
- 4.1.2 Custom Chip
- 4.2 Global Microfluidic Chip Solution Sales Value by Type
- 4.2.1 Global Microfluidic Chip Solution Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Microfluidic Chip Solution Sales Value by Type (2021-2032)
- 4.2.3 Global Microfluidic Chip Solution Sales Value Share by Type (2021-2032)
5 Microfluidic Chip Solution Market by Application
- 5.1 Microfluidic Chip Solution Application Introduction
- 5.1.1 Chemical Analysis
- 5.1.2 Environmental Monitoring
- 5.1.3 Biomedical Science
- 5.1.4 Others
- 5.2 Global Microfluidic Chip Solution Sales Value by Application
- 5.2.1 Global Microfluidic Chip Solution Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Microfluidic Chip Solution Sales Value by Application (2021-2032)
- 5.2.3 Global Microfluidic Chip Solution Sales Value Share by Application (2021-2032)
6 Microfluidic Chip Solution Regional Value Analysis
- 6.1 Global Microfluidic Chip Solution Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Microfluidic Chip Solution Sales Value by Region (2021-2032)
- 6.2.1 Global Microfluidic Chip Solution Sales Value by Region: 2021-2026
- 6.2.2 Global Microfluidic Chip Solution Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Microfluidic Chip Solution Sales Value (2021-2032)
- 6.3.2 North America Microfluidic Chip Solution Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Microfluidic Chip Solution Sales Value (2021-2032)
- 6.4.2 Europe Microfluidic Chip Solution Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Microfluidic Chip Solution Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Microfluidic Chip Solution Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Microfluidic Chip Solution Sales Value (2021-2032)
- 6.6.2 South America Microfluidic Chip Solution Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Microfluidic Chip Solution Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Microfluidic Chip Solution Sales Value Share by Country, 2025 VS 2032
7 Microfluidic Chip Solution Country-level Value Analysis
- 7.1 Global Microfluidic Chip Solution Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Microfluidic Chip Solution Sales Value by Country (2021-2032)
- 7.2.1 Global Microfluidic Chip Solution Sales Value by Country (2021-2026)
- 7.2.2 Global Microfluidic Chip Solution Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.7.2 France Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.14.2 China Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.17.2 India Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Microfluidic Chip Solution Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Microfluidic Chip Solution Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Microfluidic Chip Solution Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Singleron
- 8.1.1 Singleron Company Information
- 8.1.2 Singleron Business Overview
- 8.1.3 Singleron Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.1.4 Singleron Microfluidic Chip Solution Product Portfolio
- 8.1.5 Singleron Recent Developments
- 8.2 Suzhou WenHao Microfluidic Technology
- 8.2.1 Suzhou WenHao Microfluidic Technology Company Information
- 8.2.2 Suzhou WenHao Microfluidic Technology Business Overview
- 8.2.3 Suzhou WenHao Microfluidic Technology Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.2.4 Suzhou WenHao Microfluidic Technology Microfluidic Chip Solution Product Portfolio
- 8.2.5 Suzhou WenHao Microfluidic Technology Recent Developments
- 8.3 Shenzhen Micropoint Biotechnologies
- 8.3.1 Shenzhen Micropoint Biotechnologies Company Information
- 8.3.2 Shenzhen Micropoint Biotechnologies Business Overview
- 8.3.3 Shenzhen Micropoint Biotechnologies Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.3.4 Shenzhen Micropoint Biotechnologies Microfluidic Chip Solution Product Portfolio
- 8.3.5 Shenzhen Micropoint Biotechnologies Recent Developments
- 8.4 FluidicLab
- 8.4.1 FluidicLab Company Information
- 8.4.2 FluidicLab Business Overview
- 8.4.3 FluidicLab Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.4.4 FluidicLab Microfluidic Chip Solution Product Portfolio
- 8.4.5 FluidicLab Recent Developments
- 8.5 I'M MICROSPHERE
- 8.5.1 I'M MICROSPHERE Company Information
- 8.5.2 I'M MICROSPHERE Business Overview
- 8.5.3 I'M MICROSPHERE Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.5.4 I'M MICROSPHERE Microfluidic Chip Solution Product Portfolio
- 8.5.5 I'M MICROSPHERE Recent Developments
- 8.6 Thermo-Fisher-Scientific
- 8.6.1 Thermo-Fisher-Scientific Company Information
- 8.6.2 Thermo-Fisher-Scientific Business Overview
- 8.6.3 Thermo-Fisher-Scientific Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.6.4 Thermo-Fisher-Scientific Microfluidic Chip Solution Product Portfolio
- 8.6.5 Thermo-Fisher-Scientific Recent Developments
- 8.7 Micro Systems
- 8.7.1 Micro Systems Company Information
- 8.7.2 Micro Systems Business Overview
- 8.7.3 Micro Systems Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.7.4 Micro Systems Microfluidic Chip Solution Product Portfolio
- 8.7.5 Micro Systems Recent Developments
- 8.8 LabSmith
- 8.8.1 LabSmith Company Information
- 8.8.2 LabSmith Business Overview
- 8.8.3 LabSmith Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.8.4 LabSmith Microfluidic Chip Solution Product Portfolio
- 8.8.5 LabSmith Recent Developments
- 8.9 KYODO
- 8.9.1 KYODO Company Information
- 8.9.2 KYODO Business Overview
- 8.9.3 KYODO Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.9.4 KYODO Microfluidic Chip Solution Product Portfolio
- 8.9.5 KYODO Recent Developments
- 8.10 Fivephoton Biochemicals
- 8.10.1 Fivephoton Biochemicals Company Information
- 8.10.2 Fivephoton Biochemicals Business Overview
- 8.10.3 Fivephoton Biochemicals Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.10.4 Fivephoton Biochemicals Microfluidic Chip Solution Product Portfolio
- 8.10.5 Fivephoton Biochemicals Recent Developments
- 8.11 Enplas
- 8.11.1 Enplas Company Information
- 8.11.2 Enplas Business Overview
- 8.11.3 Enplas Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.11.4 Enplas Microfluidic Chip Solution Product Portfolio
- 8.11.5 Enplas Recent Developments
- 8.12 Dolomite
- 8.12.1 Dolomite Company Information
- 8.12.2 Dolomite Business Overview
- 8.12.3 Dolomite Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.12.4 Dolomite Microfluidic Chip Solution Product Portfolio
- 8.12.5 Dolomite Recent Developments
- 8.13 CPS Fluidics
- 8.13.1 CPS Fluidics Company Information
- 8.13.2 CPS Fluidics Business Overview
- 8.13.3 CPS Fluidics Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.13.4 CPS Fluidics Microfluidic Chip Solution Product Portfolio
- 8.13.5 CPS Fluidics Recent Developments
- 8.14 Bio-Rad-Laboratories
- 8.14.1 Bio-Rad-Laboratories Company Information
- 8.14.2 Bio-Rad-Laboratories Business Overview
- 8.14.3 Bio-Rad-Laboratories Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.14.4 Bio-Rad-Laboratories Microfluidic Chip Solution Product Portfolio
- 8.14.5 Bio-Rad-Laboratories Recent Developments
- 8.15 Atomica
- 8.15.1 Atomica Company Information
- 8.15.2 Atomica Business Overview
- 8.15.3 Atomica Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.15.4 Atomica Microfluidic Chip Solution Product Portfolio
- 8.15.5 Atomica Recent Developments
- 8.16 Agilent-Technologies
- 8.16.1 Agilent-Technologies Company Information
- 8.16.2 Agilent-Technologies Business Overview
- 8.16.3 Agilent-Technologies Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.16.4 Agilent-Technologies Microfluidic Chip Solution Product Portfolio
- 8.16.5 Agilent-Technologies Recent Developments
- 8.17 AGC Inc.
- 8.17.1 AGC Inc. Company Information
- 8.17.2 AGC Inc. Business Overview
- 8.17.3 AGC Inc. Microfluidic Chip Solution Revenue and Gross Margin (2021-2026)
- 8.17.4 AGC Inc. Microfluidic Chip Solution Product Portfolio
- 8.17.5 AGC Inc. Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst